Sitagliptin added to ongoing treatment with metformin improved glycemic control and was well tolerated in Japanese patients with type 2 diabetes (T2DM)

被引：0
|
作者：
Kadowaki, Takashi
Tajima, Naoko
Odawara, Masato
Nishii, Mikio
Nonaka, Kenji
Stein, Peter P.
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A589 / A590
页数：2
相关论文
共 50 条
  • [1] Sitagliptin added to ongoing treatment with pioglitazone improved glycemic control and was well tolerated in Japanese patients with type 2 diabetes (T2DM)
    Kashiwagi, Atsunori
    Tajima, Naoko
    Kadowaki, Takashi
    Nonaka, Kenji
    Moto, Tarooka
    Okuyama, Kotoba
    Nishii, Mikio
    Stein, Peter R.
    [J]. DIABETES, 2008, 57 : A590 - A590
  • [2] Sitagliptin added to ongoing treatment with glimepiride improved glycemic control and was well tolerated in Japanese patients with type 2 diabetes (T2DM)
    Tajima, Naoko
    Kadowaki, Takashi
    Odawara, Masato
    Nishii, Mikio
    Nonaka, Kenji
    Stein, Peter P.
    [J]. DIABETES, 2008, 57 : A589 - A589
  • [3] Sitagliptin Improved Glycemic Control and Was Well Tolerated When Added to Voglibose Monotherapy in Patients with Type 2 Diabetes
    Tajima, Naoko
    Kadowaki, Takashi
    Suzuki, Hideyo
    Sato, Asako
    Okuyama, Kotoba
    Minamide, Toshiomi
    Arjona Ferreira, Juan Camilo
    [J]. DIABETES, 2010, 59 : A157 - A157
  • [4] Addition of Sitagliptin Improved Glycemic Control and Was Well Tolerated in Japanese Patients with Type 2 Diabetes on Glinides Monotherapy
    Tajima, Naoko
    Kadowaki, Takashi
    Odawara, Masato
    Minamide, Toshiomi
    Seki, Akiteru
    Oki, Kaori
    Narita, Hirohisa
    Gantz, Ira
    [J]. DIABETES, 2014, 63 : A268 - A268
  • [5] Sitagliptin Added to Ongoing Metformin Therapy in Chinese Patients with Type 2 Diabetes Significantly Enhances Glycemic Control
    Yang, Wenying
    Guan, Yanfen
    Yue Shentu
    Zhi Li
    Johnson-Levonas, Amy O.
    Engel, Samuel S.
    Kaufman, Keith D.
    Goldstein, Barry J.
    Alba, Maria
    [J]. DIABETES, 2011, 60 : A306 - A306
  • [6] Sitagliptin added to ongoing treatment with pioglitazone study up to 52 weeks in Japanese patients with T2DM
    Maegawa, H.
    Kashiwagi, A.
    Tajima, N.
    Kadowaki, T.
    Nonaka, K.
    Okamoto, T.
    Okuyama, K.
    Nishii, M.
    Amatruda, J. M.
    [J]. DIABETOLOGIA, 2008, 51 : S365 - S365
  • [7] Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes
    Kashiwagi, Atsunori
    Kadowaki, Takashi
    Tajima, Naoko
    Nonaka, Kenji
    Taniguchi, Tadaaki
    Nishii, Mikio
    Ferreira, Juan Camilo Arjona
    Amatruda, John M.
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2011, 2 (05) : 381 - 390
  • [8] Saxagliptin Improves Glycemic Control and Is Well Tolerated in Patients with Type 2 Diabetes Mellitus (T2DM) and Renal Impairment Compared with Placebo
    Owens, David R.
    Swallow, Ros
    Jones, Peter
    Dugi, Klaus A.
    Woerle, Hans-Juergen
    [J]. DIABETES, 2010, 59 : A149 - A150
  • [9] Improved glycemic control with oral recombinant human insulin in patients with type 2 diabetes (T2DM) inadequately controlled on metformin
    Goldberg, Michael
    Dinh, Steve
    Castelli, Cristina
    Majuru, Shingai
    Arbit, Ehud
    [J]. DIABETES, 2007, 56 : A121 - A122
  • [10] Sitagliptin added to ongoing metformin therapy enhanced glycemic control and beta-cell function in patients with type 2 diabetes
    Karasik, Avraham
    Charbonnel, Bernard
    Liu, Ji
    Wu, Mei
    Meehan, Alan
    Meininger, Gary
    [J]. DIABETES, 2006, 55 : A119 - A120
12345